COMGENEX
DEAD

Serial Number

76421249

Owner

ComGenex Rt.

Attorney

Mark Lebow

Filing Date

Jun 14, 2002

Add to watchlist:

No watchlists yet
View on USPTO

COMGENEX Trademark

Serial Number: 76421249 • Registration: 2942508

COMGENEX is a trademark filed by ComGenex Rt. on June 14, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ComGenex Rt.

H-1027 Budapest
Bem rkp. 33-34 , HU

Entity Type: 03

Trademark Details

Filing Date

June 14, 2002

Registration Date

April 19, 2005

Published for Opposition

March 16, 2004

Cancellation Date

November 25, 2011

Goods & Services

Scientific apparatus and instruments, namely, computers, computer software for use in the fields of pharmaceutics, agrochemistry, medicinal chemistry, biology, biotechnology, chemical genomics and proteomics for the purpose of drug discovery and development, drug design and disposition, virtual structure handling and high throughput prediction, chemical experimentation, understanding protein structure function relationships, innovative lead evolution, diversity selection and similarity searching, virtual screening and predictions, prediction of metabolisms in human, animals, plants, estimation of toxic symptoms in humans and animals for method development and optimization; computer database management; computer software for use in controlling reactors and analytical devices; computer software for use in assisting in providing combinatorial chemistry compounds, related data, and information; computer software used in the management of organic synthesis projects in combinatorial laboratories; computer software for use in chemistry, physiochemistry, analytics and chemical databases

Pharmaceutical preparations for the treatment of a wide variety of human diseases, namely, central nervous system diseases, metabolic diseases and cancer; sanitary preparations for the treatment of a wide variety of diseases, namely, preparations for treating central nervous system diseases, metabolic diseases and caner

chemicals used in industry and science, namely, chemicals used in the discovery, development and manufacture of pharmaceuticals and drugs, and for use in agrochemistry, medicinal chemistry, biology, biotechnology, chemical genomics, proteomics, for a wide variety of goods, as well as for research in all of the foregoing industries

Scientific and industrial research; computer programming for others; updating of computer software for others

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 25, 2011 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2008 TCCA
REGISTERED-PRINCIPAL REGISTER
Apr 19, 2005 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 13, 2005 REGV
ASSIGNED TO LIE
Jan 7, 2005 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 26, 2004 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 23, 2004 SUPC
USE AMENDMENT FILED
Dec 8, 2004 IUAF
PAPER RECEIVED
Dec 8, 2004 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 8, 2004 NOAM
PUBLISHED FOR OPPOSITION
Mar 16, 2004 PUBO
NOTICE OF PUBLICATION
Feb 25, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2003 CNSA
PAPER RECEIVED
Nov 13, 2003 MAIL
CASE FILE IN TICRS
Oct 13, 2003 CFIT
EMAIL RECEIVED
Oct 2, 2003 EMRV
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2003 CRFA
FINAL REFUSAL MAILED
May 23, 2003 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2003 CRFA
PAPER RECEIVED
Mar 24, 2003 MAIL
NON-FINAL ACTION MAILED
Sep 23, 2002 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2002 DOCK